Case number 3:22-cv-00137
Nexus Pharmaceuticals, Inc. v. Nephron SC, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 9, 2023 | 37 | STIPULATION of Dismissal Without Prejudice by Nexus Pharmaceuticals, Inc.. (Dharamsi, Tasneem) (Entered: 01/09/2023) (2) |
| Dec 19, 2022 | 36 | TEXT ORDER granting 35 Joint MOTION for Extension of Time. (Nexus Pharmaceuticals, Inc. answer due 1/17/2023; Defendant's Discovery Responses due by 1/20/2023) Signed by Honorable Mary Geiger Lewis on 12/19/2022. (cbru, ) (Entered: 12/19/2022) (0) |
| Dec 19, 2022 | 35 | Joint MOTION for Extension of Time by Nexus Pharmaceuticals, Inc. Response to Motion due by 1/3/2023. Add an additional 3 days only if served by mail or otherwise allowed under Fed. R. Civ. P. 6 or Fed. R. Crim. P. 45. (Attachments: # 1 Proposed Order) Proposed order is being emailed to chambers with copy to opposing counsel.(Dharamsi, Tasneem) Modified to correct motion relief on 12/19/2022 (cbru, ). (Entered: 12/19/2022) (0) |
| Dec 6, 2022 | 34 | ANSWER to 1 Complaint , COUNTERCLAIM against Nexus Pharmaceuticals, Inc. by Nephron SC, Inc..(Mergo, Nikole) (Entered: 12/06/2022) (17) |
| Nov 16, 2022 | 32 | Joint MOTION to Amend/Correct 12 Scheduling Order, MOTION for Extension of Time to File Answer re 1 Complaint by Nexus Pharmaceuticals, Inc. Response to Motion due by 11/30/2022. Add an additional 3 days only if served by mail or otherwise allowed under Fed. R. Civ. P. 6 or Fed. R. Crim. P. 45. (Attachments: # 1 Proposed Order) Proposed order is being emailed to chambers with copy to opposing counsel.(Dharamsi, Tasneem). Added additional motion relief on 11/16/2022 (cbru, ). (Entered: 11/16/2022) (Proposed Order) (6) |
| Nov 16, 2022 | 33 | AMENDED SCHEDULING ORDER: Nephron SC, Inc. answer due 12/6/2022, Motions to Amend Pleadings due by 7/21/2023,, Plaintiff ID of Expert Witness concerning infringement due by 11/3/2023, Plaintiff ID of Expert Witness concerning validity due by 1/12/2024, Defendant ID of Expert Witnesses Due by 12/8/2023, Records Custodian Affidavit due by 12/8/2023, Fact Discovery due by 9/29/2023, Expert Discovery due by 3/11/2024, Motion in Limine due by 3/27/2024, Motions due by 3/27/2024, Rule 26(a)(3) Disclosures due by 4/24/2024, Jury Selection Deadline 5/27/2024, Mediation Due by 10/27/2023, Second Mediation Due by 3/21/2024, Joint Claim Construction Chart due by 3/15/2023, Joint Claim Construction Brief due by 6/9/2023. Signed by Honorable Mary Geiger Lewis on 11/6/2022. (cbru, ) (Entered: 11/16/2022) (3) |
| Nov 16, 2022 | 32 | Joint MOTION to Amend/Correct 12 Scheduling Order, MOTION for Extension of Time to File Answer re 1 Complaint by Nexus Pharmaceuticals, Inc. Response to Motion due by 11/30/2022. Add an additional 3 days only if served by mail or otherwise allowed under Fed. R. Civ. P. 6 or Fed. R. Crim. P. 45. (Attachments: # 1 Proposed Order) Proposed order is being emailed to chambers with copy to opposing counsel.(Dharamsi, Tasneem). Added additional motion relief on 11/16/2022 (cbru, ). (Entered: 11/16/2022) (Main Document) (2) |
| Nov 16, 2022 | 31 | TEXT ORDER: Plaintiff's 30 motion for an extension of time is DENIED for failure to show good cause. Moreover, the Court's deadline to submit a proposed scheduling order applied to both parties, and Defendant failed to respond to the order. Accordingly, no later than today, November 16, 2022, at 12:00 P.M. (noon), the parties shall submit a proposed scheduling order. If the parties fail to do so, they may face sanctions including, but not limited to, a monetary sanction up to $500. IT IS SO ORDERED. (Proposed Amended Scheduling Order due by 11/16/2022) Signed by Honorable Mary Geiger Lewis on 11/16/2022. (cbru, ) (Entered: 11/16/2022) (0) |
| Nov 15, 2022 | 30 | MOTION for Extension of Time to Submit Proposed Amended Scheduling Order by Nexus Pharmaceuticals, Inc.. Response to Motion due by 11/29/2022. Add an additional 3 days only if served by mail or otherwise allowed under Fed. R. Civ. P. 6 or Fed. R. Crim. P. 45. (Attachments: # 1 Proposed Order)Proposed order is being emailed to chambers with copy to opposing counsel.(Dharamsi, Tasneem) (Entered: 11/15/2022) (Proposed Order) (1) |
| Nov 15, 2022 | 30 | MOTION for Extension of Time to Submit Proposed Amended Scheduling Order by Nexus Pharmaceuticals, Inc.. Response to Motion due by 11/29/2022. Add an additional 3 days only if served by mail or otherwise allowed under Fed. R. Civ. P. 6 or Fed. R. Crim. P. 45. (Attachments: # 1 Proposed Order)Proposed order is being emailed to chambers with copy to opposing counsel.(Dharamsi, Tasneem) (Entered: 11/15/2022) (Main Document) (2) |
| Nov 8, 2022 | 29 | MEMORANDUM OPINION AND ORDER LIFTING STAY, denying 10 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM. (Proposed Amended Scheduling Order due by 11/15/2022) Signed by Honorable Mary Geiger Lewis on 11/8/2022. (cbru, ) (Entered: 11/08/2022) (7) |
| May 19, 2022 | 27 | TEXT ORDER: Defendant's 20 motion to stay discovery is GRANTED. All deadlines in this matter are STAYED pending the Court's ruling on Defendant's 10 motion to dismiss. In the event the Court denies Defendant's 10 motion to dismiss, the parties shall submit a proposed amended scheduling order within one week of the Court's order. IT IS SO ORDERED. Signed by Honorable Mary Geiger Lewis on 5/19/2022. (cbru, ) (Entered: 05/19/2022) (0) |
| May 19, 2022 | N/A | Order Staying Case (0) Docket Text:TEXT ORDER: Defendant's [20] motion to stay discovery is GRANTED. All deadlines in this matter are STAYED pending the Court's ruling on Defendant's [10] motion to dismiss. In the event the Court denies Defendant's [10] motion to dismiss, the parties shall submit a proposed amended scheduling order within one week of the Court's order. IT IS SO ORDERED. Signed by Honorable Mary Geiger Lewis on 5/19/2022. (cbru, ) |
| May 2, 2022 | 26 | Reply to Response to Motion (10) Docket Text: REPLY to Response to Motion re [20] MOTION to Stay Discovery Pending Disposition of Motion to Dismiss Response filed by Nephron SC, Inc.. (Mergo, Nikole) |
| May 2, 2022 | 25 | Exhibit A - Notice Letter (16) |
| May 2, 2022 | 25 | Main Document (16) Docket Text: REPLY to Response to Motion re [10] MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM Response filed by Nephron SC, Inc.. (Attachments: # (1) Exhibit A - Notice Letter)(Mergo, Nikole) Modified to edit text on 5/3/2022 (cbru, ). |
| Apr 25, 2022 | 24 | Response in Opposition to Motion (14) Docket Text: RESPONSE in Opposition re [20] MOTION to Stay Discovery Pending Disposition of Motion to Dismiss Response filed by Nexus Pharmaceuticals, Inc..Reply to Response to Motion due by 5/2/2022 Add an additional 3 days only if served by mail or otherwise allowed under Fed. R. Civ. P. 6. (Dharamsi, Tasneem) |
| Apr 14, 2022 | N/A | Order on Motion for Extension of Time to File Response/Reply (0) Docket Text:TEXT ORDER granting [22] Motion for Extension of Time to File Response/Reply re [10] MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM. (Reply due by 5/2/2022) Signed by Honorable Mary Geiger Lewis on 4/14/2022.(cbru, ) |
| Apr 14, 2022 | 22 | Motion for Extension of Time to File Response/Reply (3) Docket Text: MOTION for Extension of Time to File Response/Reply re [10] MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Nephron SC, Inc. Response to Motion due by 4/28/2022. Add an additional 3 days only if served by mail or otherwise allowed under Fed. R. Civ. P. 6 or Fed. R. Crim. P. 45. No proposed order.(Mergo, Nikole) Modified to link correct event to associated event on 4/14/2022 (cbru, ). |
| Apr 11, 2022 | 17 | Rule 26(f) Report (2) Docket Text: Rule 26(f) Report by Nexus Pharmaceuticals, Inc..(Hinson, Amy Elizabeth) |
| Apr 11, 2022 | 18 | Response in Opposition to Motion (25) Docket Text: RESPONSE in Opposition re [10] MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM Response filed by Nexus Pharmaceuticals, Inc..Reply to Response to Motion due by 4/18/2022 Add an additional 3 days only if served by mail or otherwise allowed under Fed. R. Civ. P. 6. (Dharamsi, Tasneem) |
| Apr 11, 2022 | 19 | Local Rule 26.03 Answers to Interrogatories (9) Docket Text: Local Rule 26.03 Answers to Interrogatories by Nexus Pharmaceuticals, Inc..(Dharamsi, Tasneem) |
| Apr 11, 2022 | 20 | Main Document (3) Docket Text: MOTION to Stay Discovery Pending Disposition of Motion to Dismiss by Nephron SC, Inc. Response to Motion due by 4/25/2022. Add an additional 3 days only if served by mail or otherwise allowed under Fed. R. Civ. P. 6 or Fed. R. Crim. P. 45. (Attachments: # (1) Memo in Support, # (2) Exhibit A - Nexus's First Set of Requests for Production to Defendant & Nexus's First Set of Requests for Interrogatories to Defendant)No proposed order.(Mergo, Nikole) Modified to edit text on 4/12/2022 (cbru, ). |
| Apr 11, 2022 | 20 | Memo in Support (14) |
| Apr 11, 2022 | 20 | Exhibit A - Nexus's First Set of Requests for Production to Defendant & Nex (25) |
| Apr 11, 2022 | 21 | Local Rule 26.03 Answers to Interrogatories (6) Docket Text: Local Rule 26.03 Answers to Interrogatories by Nephron SC, Inc. Refiled by the Clerk to correct event type. (cbru, ) |
| Apr 11, 2022 | 16 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Nikole Setzler Mergo on behalf of Nephron SC, Inc. (Mergo, Nikole) |
| Mar 18, 2022 | N/A | Order on Motion for Extension of Time to File Response/Reply (0) Docket Text:TEXT ORDER granting [14] Motion for Extension of Time to File Response/Reply as to [10] MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM. (Response to Motion due by 4/11/2022) Signed by Honorable Mary Geiger Lewis on 3/18/2022.(cbru, ) |
| Mar 18, 2022 | 14 | Proposed Order (1) |
| Mar 18, 2022 | 14 | Main Document (2) Docket Text: Consent MOTION for Extension of Time to File Response/Reply as to [10] MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Nexus Pharmaceuticals, Inc.. Response to Motion due by 4/1/2022. Add an additional 3 days only if served by mail or otherwise allowed under Fed. R. Civ. P. 6 or Fed. R. Crim. P. 45. (Attachments: # (1) Proposed Order)Proposed order is being emailed to chambers with copy to opposing counsel.(Hinson, Amy Elizabeth) |
| Mar 8, 2022 | 13 | Mediation Order (2) Docket Text:MEDIATION ORDER. Signed by Honorable Mary Geiger Lewis on 3/8/2022. (cbru, ) |
| Mar 8, 2022 | 12 | Scheduling Order (7) Docket Text:CONFERENCE AND SCHEDULING ORDER: Rule 26 Report due by 4/11/2022, Motions to Amend Pleadings due by 5/6/2022, Plaintiffs ID of Expert Witness due by 6/6/2022, Defendants ID of Expert Witnesses Due by 7/5/2022, Records Custodian Affidavit due by 7/5/2022, Discovery due by 9/6/2022, Motion in Limine due by 12/19/2022, Motions due by 9/19/2022, Rule 26(a)(3) Disclosures due by 12/2/2022, Jury Selection Deadline 1/9/2023, Mediation Due by 11/17/2022. Signed by Honorable Mary Geiger Lewis on 3/8/2022. (cbru, ) |
| Mar 7, 2022 | 11 | Local Rule 26.01 Answers to Interrogatories (4) Docket Text: Local Rule 26.01 Answers to Interrogatories by Nephron SC, Inc..(Ricard, Rhett) |
| Mar 7, 2022 | 10 | Exhibit 1 - Patent Exhibit (2) |
| Mar 7, 2022 | 10 | Memo in Support (10) |
| Mar 7, 2022 | 10 | Main Document (3) Docket Text: MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Nephron SC, Inc.. Response to Motion due by 3/21/2022. Add an additional 3 days only if served by mail or otherwise allowed under Fed. R. Civ. P. 6 or Fed. R. Crim. P. 45. (Attachments: # (1) Memo in Support, # (2) Exhibit 1 - Patent Exhibit)No proposed order.(Ricard, Rhett) Modified to edit text on 3/7/2022 (cbru, ). |
| Mar 7, 2022 | 9 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Rhett Douglas Ricard on behalf of Nephron SC, Inc. (Ricard, Rhett) (Main Document 9 replaced on 3/8/2022) (cbru, ). |
| Feb 8, 2022 | 7 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Seth Lee Hudson on behalf of Nephron SC, Inc. (Hudson, Seth) |
| Jan 27, 2022 | 6 | Exhibit A - Affidavit of Service (2) |
| Jan 27, 2022 | 6 | Main Document (2) Docket Text: SUMMONS Returned Executed by Nexus Pharmaceuticals, Inc.. Nephron SC, Inc. served on 1/24/2022, answer due 2/14/2022. (Attachments: # (1) Exhibit A - Affidavit of Service)(Dharamsi, Tasneem) |
| Jan 18, 2022 | 5 | Summons Issued (2) Docket Text: Summons Issued as to Nephron SC, Inc. (cbru, ) |
| Jan 14, 2022 | 1 | Complaint* (1) |
| Jan 14, 2022 | 4 | Report on the Filing or Determination of Patent or Trademark (1) Docket Text: Report on the Filing or Determination of an Action or Appeal Regarding a Patent or Trademark. (cbru, ) |
| Jan 14, 2022 | 3 | Local Rule 26.01 Answers to Interrogatories (3) Docket Text: Local Rule 26.01 Answers to Interrogatories by Nexus Pharmaceuticals, Inc.(cbru, ) |
| Jan 14, 2022 | 1 | Exhibit A - U.S. Patent No. 11,090,278 (26) |
| Jan 14, 2022 | 1 | Main Document (11) Docket Text: COMPLAINT against Nephron SC, Inc. (Filing fee $402 receipt number ASCDC-10282422) filed by Nexus Pharmaceuticals, Inc. Service due by 4/14/2022 (Attachments: # (1) Exhibit A - U.S. Patent No. 11,090,278)(cbru, ) |
